---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-008716"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2022-12-30T23:59:59+00:00"
generated_at: "2026-06-20T21:22:19.584925+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals grants annual options to execs and directors at $1.08 strike

## Summary
- Board revised Director Compensation Plan, reducing annual director option grants to 20,000 per director.
- CEO Amy Trombly awarded 40,000 options; COO Bruce Thornton 40,000; CFO Chad White 9,753 (prorated).
- Exercise price $1.08 per share; options vest in three equal annual tranches over three years.
- Options accelerate on change of control and as provided in executive employment agreements.

## SEC filing metadata
- accession: 0001683168-22-008716
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2022-12-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316822008716/0001683168-22-008716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316822008716/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-008716
- JSON: https://secwatch.observer/filing/0001683168-22-008716.json
- Plain text: https://secwatch.observer/filing/0001683168-22-008716.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.